Literature DB >> 20648089

Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.

Mário L R Monteiro1, Beatriz K Zambon, Leonardo P Cunha.   

Abstract

OBJECTIVE: To investigate clinical and MRI findings that are predictive of both visual loss in patients with pituitary adenomas and visual recovery after treatment.
DESIGN: Cohort study. PARTICIPANTS: Thirty patients (60 eyes) with pituitary adenoma.
METHODS: Patients underwent neuro-ophthalmic examination and MRI before and after optic chiasm decompression. Visual field (VF) was assessed using the mean deviation in standard automated perimetry (SAP) and temporal mean defect, the average of 22 temporal values of the total deviation plot. Tumour size was measured on sagittal and coronal cuts.
RESULTS: Visual loss was found in 47 eyes; 35 had optic atrophy (subtle in 9, moderate in 14, and severe in 12). Before treatment, the average SAP mean deviation and temporal mean defect were -11.78 (SD 8.56) dB and -18.66 (SD 11.20) dB, respectively. The chiasm was 17.3 (SD 6.2, range 10-34) mm above the reference line on the sagittal and 21.8 (SD 8.3, range 12-39) mm on the coronal images. Tumour size correlated with the severity of VF defect. VF improvement occurred in 80% of eyes after treatment. The degree of optic atrophy, visual loss, and tumour size were significantly associated with improvement after treatment.
CONCLUSIONS: The best predictive factor for visual loss was tumour size, and factors related to visual recovery were the degree of optic atrophy, the severity of VF defect, and the tumour size. Diagnosing pituitary adenomas before optic atrophy becomes severe may be related to a better prognosis in such patients.

Entities:  

Mesh:

Year:  2010        PMID: 20648089     DOI: 10.3129/i09-276

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  15 in total

1.  Predictive factors of visual function recovery after pituitary adenoma resection: a literature review and Meta-analysis.

Authors:  Min Sun; Zhi-Qiang Zhang; Chi-Yuan Ma; Sui-Hua Chen; Xin-Jian Chen
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Invited Commentary: Ganglion Cell Complex Measurement in Compressive Optic Neuropathy.

Authors:  Jonathan C Horton
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

3.  Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method.

Authors:  Lina Raffaella Barzaghi; Marzia Medone; Marco Losa; Stefania Bianchi; Massimo Giovanelli; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-11-15       Impact factor: 3.042

4.  Quantitative and functional visual field outcomes after endoscopic trans-sphenoidal pituitary adenectomy.

Authors:  Dhruv Parikh; James M W Robins; Tess Garretty; Asim J Sheikh; Atul K Tyagi; Paul A Nix; Nick I Phillips
Journal:  Acta Neurochir (Wien)       Date:  2022-04-15       Impact factor: 2.216

5.  Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas.

Authors:  Mendel Castle-Kirszbaum; Yi Yuen Wang; James King; Tony Goldschlager
Journal:  Neurosurg Rev       Date:  2021-08-09       Impact factor: 3.042

6.  Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study.

Authors:  Li Xia; Jia Wenhui; Yang Xiaowen; Xie Wenfang; Zhang Wei; Hu Yanjun; Peng Xiaoyan
Journal:  Pituitary       Date:  2022-07-14       Impact factor: 3.599

7.  The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases.

Authors:  Ren-Wen Ho; Hsiu-Mei Huang; Jih-Tsun Ho
Journal:  J Korean Neurosurg Soc       Date:  2015-01-31

8.  Reconciling visual field defects and retinal nerve fibre layer asymmetric patterns in retrograde degeneration: an extended case series.

Authors:  Barbara Zangerl; Andrew Whatham; Juno Kim; Agnes Choi; Nagi N Assaad; Michael P Hennessy; Michael Kalloniatis
Journal:  Clin Exp Optom       Date:  2016-10-11       Impact factor: 2.742

9.  Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.

Authors:  Rajesh Verma; Mani Gupta; Tejendra Sukdeo Chaudhari
Journal:  J Neurosci Rural Pract       Date:  2014-10

10.  [Optical coherence tomography as a predictor of visual recovery in patients with pituitary macroadenomas].

Authors:  Sofía Beltrame; Jorge Rasmussen; Pedro Plou; Moira Altszul; Claudio Yampolsky; Pablo Ajler
Journal:  Surg Neurol Int       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.